2002 Conference Publication Puberty and bone mineral accrual in cystic fibrosisBuntain, H. M., Greer, R. M., Batch, J., Wong, J., Lewindon, P., Schluter, P., Bell, S. C., Potter, J. and Wainwright, C. E. (2002). Puberty and bone mineral accrual in cystic fibrosis. TSANZ 2002 Annual Scientific Meeting. Respirology, Cairns, QLD, Australia, 22-27 March 2002. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2004.supp_2.x |
2002 Conference Publication Age appropriate pubertal development in cystic fibrosisBuntain, H., Greer, R. M., Schluter, P., Batch, J., Bell, S. C. and Wainwright, C. E. (2002). Age appropriate pubertal development in cystic fibrosis. The 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70012 |
2002 Conference Publication Rifampicin and fusidic acid reduces the frequency of MRSA isolation and need for intravenous antibiotics in adult patients with cystic fibrosis and chronic MRSA infectionGarske, L., Bunting, J., Franks, C., Masel, P. and Bell, S. (2002). Rifampicin and fusidic acid reduces the frequency of MRSA isolation and need for intravenous antibiotics in adult patients with cystic fibrosis and chronic MRSA infection. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia. |
2002 Journal Article Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosisGarske, L. A. and Bell, S. C. (2002). Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis. Chest, 121 (4), 1363-1364. doi: 10.1378/chest.121.4.1363 |
2002 Conference Publication A study of the use of complementary and alternative medicines (CAM) in adults with cystic fibrosis (CF)Phillips, J., Bajramovic, J. and Bell, S. (2002). A study of the use of complementary and alternative medicines (CAM) in adults with cystic fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia. |
2002 Conference Publication Long-term treatment with azithromycin results in reduced ex-vivo inflammatory cytokine production in adults with cystic fibrosisBell, S. C., Seeney, S., Walmsley, K., Wolter, J. M., Bowler, S. D. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced ex-vivo inflammatory cytokine production in adults with cystic fibrosis. 16th Annual North American Cystic Fibrosis Conference, Louisiana, USA, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70010 |
2002 Conference Publication Long-term treatment with azithromycin results in reduced in vitro inflammatory cytokine production in adults with cystic fibrosisBowler, S. D., Seeney, S., Walmsley, K., Wolter, J.M., Bell, S. C. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced in vitro inflammatory cytokine production in adults with cystic fibrosis. TSANZ Annual Scientific Meeting, Cairns, Queensland, 22-27 March, 2002. Carlton: Blackwell Asia. doi: 10.1111/j.1440-1843.2004.supp_1.x |
2002 Conference Publication Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999Cooper, P., McKay, K., Bobosevich, Z. and Bell, S. (2002). Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia. |
2002 Conference Publication Antibiotic desensitisation in adults with cystic fibrosisBurrows, J., Toon, M. and Bell, S. C. (2002). Antibiotic desensitisation in adults with cystic fibrosis. SHPA State Conference 2002 - Reducing risk: the cornerstone of hospital pharmacy, Brisbane, 1-3 Nov. 2002. Brisbane: SHPA Qld. |
2002 Conference Publication Cost of providing nutritional support for adult patients with cystif fibrosis (CF)McMillan, J., Matson, A., Matson, K. and Bell, S. (2002). Cost of providing nutritional support for adult patients with cystif fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia. |
2002 Journal Article Optimising nutrition in cystic fibrosisBell, S. C. and Shepherd, R. W. (2002). Optimising nutrition in cystic fibrosis. Journal of Cystic Fibrosis, 1 (2), 47-50. doi: 10.1016/S1569-1993(02)00031-0 |
2001 Journal Article Cost of physiotherapy in CFStallard, K., Seale, H. and Bell, S.C. (2001). Cost of physiotherapy in CF. Thorax, 56 (12), 980-980. doi: 10.1136/thorax.56.12.980 |
2001 Journal Article Azithromycin (azm) in adults with cystic fibrosis (cf)Welter, J. M., Seeney, S. L., Bowler, S. D., Masel, P. J., Bell, S. C. and McCormack, J. G. (2001). Azithromycin (azm) in adults with cystic fibrosis (cf). Respirology, 6 (SUPPL. 1). |
2001 Journal Article Manpower and costings of physiotherapy: an adult cystic fibrosis serviceBell, S. C. and Stallard, K. (2001). Manpower and costings of physiotherapy: an adult cystic fibrosis service. Respirology, 6 (SUPPL. 1). |
2001 Journal Article Pulmozyme adherence in an adult cf unitBell, S. C. and Phillips, J. A. (2001). Pulmozyme adherence in an adult cf unit. Respirology, 6 (SUPPL. 1). |
2001 Journal Article Life-threatening haemoptysis presenting as a late complication of an ovarian tumourRiha, R. L., Tubby, J., Duhig, E. E., Clarke, B. E., Haug, G. and Bell, S. C. (2001). Life-threatening haemoptysis presenting as a late complication of an ovarian tumour. International Journal of Clinical Practice, 55 (10), 729-730. |
2001 Journal Article Energy cost of physical activity in cystic fibrosisRichards, M.L., Davies, P.S.W. and Bell, S.C. (2001). Energy cost of physical activity in cystic fibrosis. European Journal of Clinical Nutrition, 55 (8), 690-697. doi: 10.1038/sj.ejcn.1601201 |
2001 Journal Article Aminoglycosides in cystic fibrosis: a descriptive study of current practice in AustraliaPhillips, J.A. and Bell, S.C. (2001). Aminoglycosides in cystic fibrosis: a descriptive study of current practice in Australia. Internal Medicine Journal, 31 (1), 23-26. doi: 10.1046/j.1445-5994.2001.00010.x |
2001 Conference Publication A prospective randomized trial of long term azithromycin (AZM) versus placebo in cystic fibrosis (CF): Impact on clinical, laboratory and quality of life (QOL) outcomesSeeney, S. L., Bowler, S., Wolter, J.M., Bell, S.C., Masel, P.J. and McCormack, J. G. (2001). A prospective randomized trial of long term azithromycin (AZM) versus placebo in cystic fibrosis (CF): Impact on clinical, laboratory and quality of life (QOL) outcomes. ASID Annual Scientific Meeting, Melbourne, Australia, 7-11 April, 2001. Carlton, Australia: Blackwell Science Asia. doi: 10.1046/j.1445-5994.2001.00318.x |
2000 Journal Article Microvascular complications in cystic fibrosis-related diabetes mellitus: A case reportScott, Andrew I.R., Clarke, Belinda E., Healy, Helen, D'Emden, Michael and Bell, Scott C. (2000). Microvascular complications in cystic fibrosis-related diabetes mellitus: A case report. Journal of the Pancreas, 1 (4), 208-210. |